Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
Status:
Completed
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Patient education may improve the effectiveness of ondansetron in preventing
nausea and vomiting in patients receiving chemotherapy.
PURPOSE: This randomized clinical trial is studying how well patient education works in
preventing nausea and vomiting in cancer patients receiving chemotherapy.